Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 14
1964 27
1965 8
1966 10
1967 24
1968 13
1969 35
1970 28
1971 22
1972 35
1973 39
1974 54
1975 39
1976 44
1977 37
1978 62
1979 63
1980 68
1981 96
1982 57
1983 59
1984 99
1985 74
1986 68
1987 109
1988 174
1989 176
1990 231
1991 222
1992 241
1993 253
1994 271
1995 346
1996 332
1997 301
1998 294
1999 328
2000 373
2001 344
2002 408
2003 448
2004 454
2005 396
2006 452
2007 458
2008 524
2009 491
2010 433
2011 499
2012 534
2013 496
2014 589
2015 607
2016 639
2017 587
2018 512
2019 458
2020 560
2021 675
2022 695
2023 630
2024 193

Text availability

Article attribute

Article type

Publication date

Search Results

15,673 results

Results by year

Filters applied: . Clear all
Page 1
Endometrial carcinosarcoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I, Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata S, Scambia G, Monk BJ. Bogani G, et al. Int J Gynecol Cancer. 2023 Feb 6;33(2):147-174. doi: 10.1136/ijgc-2022-004073. Int J Gynecol Cancer. 2023. PMID: 36585027 Review.
Although the introduction of immunotherapy plus/minus a tyrosine kinase inhibitor shifted the paradigm of treatment of patients with recurrent endometrial cancer, patients with endometrial carcinosarcoma were excluded from most studies evaluating single-agent immunotherapy …
Although the introduction of immunotherapy plus/minus a tyrosine kinase inhibitor shifted the paradigm of treatment of patients with recurre …
Soft Tissue and Uterine Leiomyosarcoma.
George S, Serrano C, Hensley ML, Ray-Coquard I. George S, et al. J Clin Oncol. 2018 Jan 10;36(2):144-150. doi: 10.1200/JCO.2017.75.9845. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220301 Free PMC article. Review.
Leiomyosarcoma (LMS) is one of the most common subtypes of soft tissue sarcoma in adults and can occur in almost any part of the body. Uterine leiomyosarcoma is the most common subtype of uterine sarcoma. Increased awareness of this unique histology has allowed for …
Leiomyosarcoma (LMS) is one of the most common subtypes of soft tissue sarcoma in adults and can occur in almost any part of the body. Ut …
Uterine mesenchymal tumours: recent advances.
Momeni-Boroujeni A, Chiang S. Momeni-Boroujeni A, et al. Histopathology. 2020 Jan;76(1):64-75. doi: 10.1111/his.14008. Histopathology. 2020. PMID: 31846533 Review.
Almost all uterine mesenchymal tumours have been historically classified as either smooth muscle or endometrial stromal neoplasms. Recent application of molecular techniques has identified numerous lesions with distinctive genetic abnormalities and clinicopathologic …
Almost all uterine mesenchymal tumours have been historically classified as either smooth muscle or endometrial stromal neoplasms …
Uterine serous carcinoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, Takehara K, Denys H, Nout RA, Lorusso D, Vaughan MM, Bini M, Takano M, Provencher D, Indini A, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Candido Dos Reis FJ, Lopez S, Mariani A, Leitao MM Jr, Raspagliesi F, Panici PB, Di Donato V, Muzii L, Colombo N, Scambia G, Pignata S, Monk BJ. Bogani G, et al. Gynecol Oncol. 2021 Jul;162(1):226-234. doi: 10.1016/j.ygyno.2021.04.029. Epub 2021 Apr 30. Gynecol Oncol. 2021. PMID: 33934848 Free PMC article. Review.
Serous endometrial cancer represents a relative rare entity accounting for about 10% of all diagnosed endometrial cancer, but it is responsible for 40% of endometrial cancer-related deaths. ...Unfortunately, despite these efforts, survival outcomes still rema …
Serous endometrial cancer represents a relative rare entity accounting for about 10% of all diagnosed endometrial cancer, but …
Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.
Sparić R, Andjić M, Babović I, Nejković L, Mitrović M, Štulić J, Pupovac M, Tinelli A. Sparić R, et al. Int J Mol Sci. 2022 Aug 27;23(17):9728. doi: 10.3390/ijms23179728. Int J Mol Sci. 2022. PMID: 36077127 Free PMC article. Review.
Uterine fibroids (UFs) are the most common benign tumors of female genital diseases, unlike uterine leiomyosarcoma (LMS), a rare and aggressive uterine cancer. ...The mutation of these genes, in addition to the altered expression and functions of their …
Uterine fibroids (UFs) are the most common benign tumors of female genital diseases, unlike uterine leiomyosarcoma (LMS), a ra …
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Croce S, et al. Gynecol Oncol. 2022 Nov;167(2):373-389. doi: 10.1016/j.ygyno.2022.07.031. Epub 2022 Sep 14. Gynecol Oncol. 2022. PMID: 36114030 Review.
Leiomyosarcoma and pleomorphic type undifferentiated uterine sarcoma belong to the first group. Low-grade and high-grade endometrial stromal sarcomas, NTRK, COL1A1::PDGFB, ALK, RET, ROS1 associated sarcomas, and SMARCA4 deficient uterine sarcoma belong to the second …
Leiomyosarcoma and pleomorphic type undifferentiated uterine sarcoma belong to the first group. Low-grade and high-grade endometrial …
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Ooi A. Ooi A. Semin Cancer Biol. 2020 Apr;61:158-166. doi: 10.1016/j.semcancer.2019.10.016. Epub 2019 Nov 2. Semin Cancer Biol. 2020. PMID: 31689495 Free PMC article. Review.
Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome with incomplete penetrance. ...HLRCC patients are genetically predisposed to develop skin leiomyomas, uterine fibroids, and the aggressive kidney ca …
Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome with incomplete pe …
Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.
Awiwi MO, Badawy M, Shaaban AM, Menias CO, Horowitz JM, Soliman M, Jensen CT, Gaballah AH, Ibarra-Rovira JJ, Feldman MK, Wang MX, Liu PS, Elsayes KM. Awiwi MO, et al. Abdom Radiol (NY). 2022 Jul;47(7):2468-2485. doi: 10.1007/s00261-022-03545-x. Epub 2022 May 13. Abdom Radiol (NY). 2022. PMID: 35554629 Review.
Uterine fibroids are the most common gynecologic neoplasm. Although non-degenerated fibroids are easily identifiable on imaging, degenerated fibroids, fibroid variants, and fibroids with unusual growth patterns can constitute a diagnostic dilemma. Identification of these a …
Uterine fibroids are the most common gynecologic neoplasm. Although non-degenerated fibroids are easily identifiable on imaging, dege …
Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A, Multinu F, De Vitis LA, Cosio S, Carinelli S, Aletti GD. Gadducci A, et al. Gynecol Oncol. 2023 Apr;171:95-105. doi: 10.1016/j.ygyno.2023.02.009. Epub 2023 Feb 24. Gynecol Oncol. 2023. PMID: 36842409 Review.
Endometrial stromal tumors (EST) are uterine mesenchymal tumors, which histologically resemble endometrial stroma of the functioning endometrium. The majority of EST are malignant tumors classified as low-grade endometrial stromal sarcoma (LG-ESS), high-grade endometrial s …
Endometrial stromal tumors (EST) are uterine mesenchymal tumors, which histologically resemble endometrial stroma of the functioning …
Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.
Hensley ML, Barrette BA, Baumann K, Gaffney D, Hamilton AL, Kim JW, Maenpaa JU, Pautier P, Siddiqui NA, Westermann AM, Ray-Coquard I. Hensley ML, et al. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S61-6. doi: 10.1097/IGC.0000000000000261. Int J Gynecol Cancer. 2014. PMID: 25341583 Free PMC article. Review.
OBJECTIVES: The Gynecologic Cancer InterGroup aimed to provide an overview of uterine and ovarian leiomyosarcoma management. ...RESULTS: The approach to management of uterine and ovarian leiomyosarcoma management is reviewed. CONCLUSIONS: Uterine and o …
OBJECTIVES: The Gynecologic Cancer InterGroup aimed to provide an overview of uterine and ovarian leiomyosarcoma management. . …
15,673 results
You have reached the last available page of results. Please see the User Guide for more information.